Thyroid hormone replacement therapy is commonly used in clinical practice to improve maternal and fetal pregnancy outcomes of patients with SCH as thyroid hormone plays an important role in mediating lipid metabolism in the human body. The gene discussed is TG; the disease is spindle cell hemangioma.